The researchers have also designed and validated a PCR test that can detect these mutations.

"We found that non-coding RNA mutations within the bacterium N. meningitidis are almost twice as likely to be associated with serious meningococcal disease, an uncommon but serious infection that can lead to death," says Edmund Loh, corresponding author and assistant professor at the Department of Microbiology, Tumor and Cell Biology at Karolinska Institutet. "This is also the first time a non-coding RNA in a bacterium has been associated with the development of a disease in humans."

N. meningitidis is a bacterium that is often found in the nose of 10 to 15 percent of the human population. In general, the bacteria do not cause any disease. However, when it does, people can become very ill rapidly and die within a few hours if left untreated.

The research work began in 2017 after a strain of the N. meningitidis bacterium was isolated from a Swedish teenager who succumbed to meningococcal meningitis. When compared with another strain of the same bacterium isolated from an asymptomatic individual, the researchers discovered mutation in a regulatory non-coding RNA molecule, known as RNA thermosensor, or RNAT, within the strain from the deceased teenager.

This finding prompted the researchers to embark on a quest to collect and investigate more than 7,000 RNAT configurations of N. meningitidis from around Europe. In total, the researchers discovered five new variants of RNATs that could be linked to illness, that is they were more likely to appear in individuals who had become ill from the bacterium.

These variants shared a common trait in that they produced more and bigger capsules that insulated the bacterium and thus helped it evade the body's immune system.

"This is the first time we have been able to associate an RNAT's effect on meningitis disease progression," says the paper's first author Jens Karlsson, PhD student at the same department. "This supports further research into this and other non-coding RNAs' potential involvement in the development of bacterial diseases."

As part of the study, the researchers also developed a quick PCR test that is capable of distinguishing these RNAT mutations.

"In the future, this PCR test may be coupled with a simple nose swab at a clinic, and in doing so, facilitate a speedy identification of these mutations, and subsequent treatment," Edmund Loh concludes.

The study was funded by the Swedish Foundation for Strategic Research, the Knut and Alice Wallenberg Foundation and the Swedish Research Council.

Facts about RNAs:

• RNAs (ribonucleic acids) are molecules that perform a range of functions within the cells. There are many kinds of RNAs, for example RNAs that carry protein-coding messages from DNA and RNAs that regulate the expression of different genes.
• Non-coding RNAs are molecules that are not translated into proteins. There are believed to be thousands of them in the human genome, many whose functions are not yet understood. Some have been linked to the development of diseases such as cancer and Alzheimer's.
• Non-coding RNAs in bacteria help regulate several physiological processes. For example, the Nobel prize winning CRISPR/Cas9 gene editing tool partly originated from the discovery of the non-coding RNA molecule, tracrRNA, which helps disarm viruses by cleaving their DNA.
• In this study, the researchers link the non-coding RNA molecule, RNA thermosensor, or RNAT, in the bacterium Neisseria meningitidis to the progression of invasive meningococcal disease. It is the first time a non-coding RNA molecule in a bacterium has been linked to the progression of a disease in humans.

Story Source:

Materials provided by Karolinska Institutet. Note: Content may be edited for style and length.

Journal Reference:

1. Jens Karlsson, Hannes Eichner, Cecilia Andersson, Susanne Jacobsson, Edmund Loh. Novel hypercapsulation RNA thermosensor variants in Neisseria meningitidis and their association with invasive meningococcal disease: a genetic and phenotypic investigation and molecular epidemiological study. The Lancet Microbe, 2020 DOI: 10/1016/S2666-5247(20)30146-4